CLOVER HEALTH ($CLOV) posted quarterly earnings results on Tuesday, May 6th. The company reported earnings of $0.05 per share, beating estimates of -$0.07 by $0.12. The company also reported revenue of $462,330,000, missing estimates of $509,550,516 by $-47,220,516.
You can see Quiver Quantitative's $CLOV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CLOVER HEALTH Insider Trading Activity
CLOVER HEALTH insiders have traded $CLOV stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:
- CARLADENISE ARMBRISTER EDWARDS sold 200,000 shares for an estimated $722,000
- BRADY PATRICK PRIEST (CEO of Home Care) sold 75,000 shares for an estimated $276,000
- KAREN SOARES (General Counsel & Secretary) sold 52,500 shares for an estimated $199,500
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CLOVER HEALTH Hedge Fund Activity
We have seen 95 institutional investors add shares of CLOVER HEALTH stock to their portfolio, and 60 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MARSHALL WACE, LLP added 2,360,902 shares (+167.6%) to their portfolio in Q4 2024, for an estimated $7,436,841
- QUBE RESEARCH & TECHNOLOGIES LTD added 1,949,126 shares (+70.7%) to their portfolio in Q4 2024, for an estimated $6,139,746
- GOLDMAN SACHS GROUP INC added 1,789,947 shares (+357.8%) to their portfolio in Q4 2024, for an estimated $5,638,333
- TUDOR INVESTMENT CORP ET AL removed 1,462,558 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $4,607,057
- RENAISSANCE TECHNOLOGIES LLC removed 1,413,300 shares (-11.3%) from their portfolio in Q4 2024, for an estimated $4,451,895
- GMT CAPITAL CORP removed 1,305,200 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $4,111,380
- MILLENNIUM MANAGEMENT LLC added 1,221,612 shares (+5071.2%) to their portfolio in Q4 2024, for an estimated $3,848,077
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CLOVER HEALTH Analyst Ratings
Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Craig-Hallum issued a "Buy" rating on 12/17/2024
To track analyst ratings and price targets for CLOVER HEALTH, check out Quiver Quantitative's $CLOV forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
